COHR•October 1, 2026 at 2:56 PM UTCTechnology Hardware & Equipment

Coherent Shares Surge on PhotonLink and Bernstein Outperform, but Valuation Stays Stretched

Read source article

What happened

Coherent Corp. shares jumped 10% to $315.71 on October 1, 2026, after traders latched onto the company's PhotonLink platform and Bernstein initiated coverage with an Outperform rating. The move reversed part of a decline from a July peak of $333.36, suggesting renewed enthusiasm for AI infrastructure suppliers like Coherent and Lumentum. However, no new fundamental disclosures accompanied the surge, and the stock still trades at a towering 144x trailing earnings and 49x EV/EBITDA. The deep value report's core concerns—weak cash conversion with only $10 million in nine-month operating cash flow, rising inventories, and heavy capex—remain unaddressed. Thus, the price action reflects sentiment rather than a change in the underlying risk-reward, which remains stretched.

Implication

The Bernstein Outperform and PhotonLink focus are positive near-term catalysts, but they do not alter the core investment case that Coherent's manufacturing advantage is already priced in. At $315, the stock still implies flawless execution of 6-inch InP ramp, sustained hyperscaler demand, and margin expansion to justify valuation. The nine-month operating cash flow of only $10 million and inventory buildup of $699 million highlight that earnings have not converted to cash, leaving little room for disappointment. Long-term investors should wait for either a pullback toward the $285 attractive entry level or evidence of improved cash conversion and margin hold above 39.6% in the next two quarters. Until then, the risk/reward remains unfavorable despite the bullish headlines.

Thesis delta

The thesis remains unchanged: Coherent's indium phosphide manufacturing edge and AI optical demand are real, but the stock price already reflects those strengths. The 10% jump on analyst initiation and platform news adds sentiment momentum without new fundamental evidence, so it does not alter the WAIT rating. The key triggers for reevaluation remain unchanged: proof of cash conversion and margin sustainability.

Confidence

medium